260 related articles for article (PubMed ID: 22801547)
1. Cooperativity and complementarity: synergies in non-classical and classical glucocorticoid signaling.
Samarasinghe RA; Witchell SF; DeFranco DB
Cell Cycle; 2012 Aug; 11(15):2819-27. PubMed ID: 22801547
[TBL] [Abstract][Full Text] [Related]
2. Nongenomic glucocorticoid receptor action regulates gap junction intercellular communication and neural progenitor cell proliferation.
Samarasinghe RA; Di Maio R; Volonte D; Galbiati F; Lewis M; Romero G; DeFranco DB
Proc Natl Acad Sci U S A; 2011 Oct; 108(40):16657-62. PubMed ID: 21930911
[TBL] [Abstract][Full Text] [Related]
3. Caveolin-1 regulates genomic action of the glucocorticoid receptor in neural stem cells.
Peffer ME; Chandran UR; Luthra S; Volonte D; Galbiati F; Garabedian MJ; Monaghan AP; DeFranco DB
Mol Cell Biol; 2014 Jul; 34(14):2611-23. PubMed ID: 24777604
[TBL] [Abstract][Full Text] [Related]
4. Negative glucocorticoid receptor response elements and their role in glucocorticoid action.
Dostert A; Heinzel T
Curr Pharm Des; 2004; 10(23):2807-16. PubMed ID: 15379669
[TBL] [Abstract][Full Text] [Related]
5. Roles of the Glucocorticoid and Mineralocorticoid Receptors in Skin Pathophysiology.
Sevilla LM; Pérez P
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29966221
[TBL] [Abstract][Full Text] [Related]
6. A novel non genomic glucocorticoid signaling mediated by a membrane palmitoylated glucocorticoid receptor cross talks with GnRH in gonadotrope cells.
Ayrout M; Simon V; Bernard V; Binart N; Cohen-Tannoudji J; Lombès M; Chauvin S
Sci Rep; 2017 May; 7(1):1537. PubMed ID: 28484221
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid-independent modulation of GR activity: Implications for immunotherapy.
Hapgood JP; Avenant C; Moliki JM
Pharmacol Ther; 2016 Sep; 165():93-113. PubMed ID: 27288728
[TBL] [Abstract][Full Text] [Related]
8. Emerging roles of glucocorticoid receptor phosphorylation in modulating glucocorticoid hormone action in health and disease.
Galliher-Beckley AJ; Cidlowski JA
IUBMB Life; 2009 Oct; 61(10):979-86. PubMed ID: 19787703
[TBL] [Abstract][Full Text] [Related]
9. Both insufficient and excessive glucocorticoid receptor-mediated signaling impair neuronal migration.
Yu H; Guo Y; Zhao Y; Zhou F; Zhao K; Li M; Wen J; He Z; Zhu X; He X
J Endocrinol; 2019 Aug; 242(2):103-114. PubMed ID: 31176306
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid receptor signaling in the eye.
Sulaiman RS; Kadmiel M; Cidlowski JA
Steroids; 2018 May; 133():60-66. PubMed ID: 29129720
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease.
De Iudicibus S; Franca R; Martelossi S; Ventura A; Decorti G
World J Gastroenterol; 2011 Mar; 17(9):1095-108. PubMed ID: 21448414
[TBL] [Abstract][Full Text] [Related]
12. Cross-talk between glucocorticoid and retinoic acid signals involving glucocorticoid receptor interaction with the homoeodomain protein Pbx1.
Subramaniam N; Campión J; Rafter I; Okret S
Biochem J; 2003 Mar; 370(Pt 3):1087-95. PubMed ID: 12487626
[TBL] [Abstract][Full Text] [Related]
13. Basal glucocorticoid receptor activation induces proliferation and inhibits neuronal differentiation of human induced pluripotent stem cell-derived neuronal precursor cells.
Nürnberg E; Horschitz S; Schloss P; Meyer-Lindenberg A
J Steroid Biochem Mol Biol; 2018 Sep; 182():119-126. PubMed ID: 29751108
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiology of Glucocorticoid Signaling.
Vitellius G; Trabado S; Bouligand J; Delemer B; Lombès M
Ann Endocrinol (Paris); 2018 Jun; 79(3):98-106. PubMed ID: 29685454
[TBL] [Abstract][Full Text] [Related]
15. Circadian glucocorticoid oscillations preserve a population of adult hippocampal neural stem cells in the aging brain.
Schouten M; Bielefeld P; Garcia-Corzo L; Passchier EMJ; Gradari S; Jungenitz T; Pons-Espinal M; Gebara E; Martín-Suárez S; Lucassen PJ; De Vries HE; Trejo JL; Schwarzacher SW; De Pietri Tonelli D; Toni N; Mira H; Encinas JM; Fitzsimons CP
Mol Psychiatry; 2020 Jul; 25(7):1382-1405. PubMed ID: 31222184
[TBL] [Abstract][Full Text] [Related]
16. Nongenomic glucocorticoid effects and their mechanisms of action in vertebrates.
Johnstone WM; Honeycutt JL; Deck CA; Borski RJ
Int Rev Cell Mol Biol; 2019; 346():51-96. PubMed ID: 31122395
[TBL] [Abstract][Full Text] [Related]
17. Identification of target genes involved in the antiproliferative effect of glucocorticoids reveals a role for nuclear factor-(kappa)B repression.
Bladh LG; Lidén J; Pazirandeh A; Rafter I; Dahlman-Wright K; Nilsson S; Okret S
Mol Endocrinol; 2005 Mar; 19(3):632-43. PubMed ID: 15528271
[TBL] [Abstract][Full Text] [Related]
18. Non-genomic effect of glucocorticoids on cardiovascular system.
Lee SR; Kim HK; Youm JB; Dizon LA; Song IS; Jeong SH; Seo DY; Ko KS; Rhee BD; Kim N; Han J
Pflugers Arch; 2012 Dec; 464(6):549-59. PubMed ID: 23001133
[TBL] [Abstract][Full Text] [Related]
19. Post-transcriptional and nongenomic effects of glucocorticoids.
Stellato C
Proc Am Thorac Soc; 2004; 1(3):255-63. PubMed ID: 16113443
[TBL] [Abstract][Full Text] [Related]
20. Membrane-initiated steroid signaling (MISS): genomic steroid action starts at the plasma membrane.
Daufeldt S; Lanz R; Alléra A
J Steroid Biochem Mol Biol; 2003 May; 85(1):9-23. PubMed ID: 12798353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
